Ophthalmology
National leader in research and provider of ophthalmic services.
Clinical Science
Research Finds Stem Cell Therapy for Retinitis Pigmentosa Safe
A team of UC Davis Health researchers has shown that CD34+ stem cells can be safely administered into retinitis pigmentosa (RP) patients’ eyes and may offer therapeutic benefits. The phase 1 trial also confirmed that these specialized cells can be readily isolated from the patient’s own bone marrow. The study was published in the American Academy of Ophthalmology journal, Ophthalmology Science.
EYE HEALTH AND VISION SCIENCE
Ophthalmologist Honored for Retina Research
The Association for Research in Vision and Ophthalmology (ARVO) has recognized Glenn Yiu, M.D., a professor of ophthalmology at UC Davis Health, with the 2024 Carl Camras Translational Research Award. The award is granted to investigators working in translational research that can lead to real-world results and improved human health. Yiu specializes in treating and researching diseases of the retina.
Research
Gene Therapy for Wet Age-Related Macular Degeneration
Ophthalmologists at UC Davis Health used an experimental gene therapy to treat a patient with wet age-related macular degeneration, or wet AMD. The treatment was part of a randomized, partially masked, controlled, phase 3 clinical study evaluating the efficacy and safety of an experimental therapy, ABBV-RGX-314, for wet AMD. UC Davis Health is one of 93 sites in the U.S. participating in the clinical trial.
Education and Engagement
Latest News
Learn About Our Expertise
Clinical Resources
Refer a Patient
We welcome the opportunity to partner with you in caring for your patient.
Browse Specialties
Our specialists are available when the need arises. Learn more about a specific health specialty.
Clinical Studies
The goal of clinical studies at UC Davis Health is to discover and share knowledge to advance health.
Awards and Recognitions
Ranked among the nation’s best hospitals
A U.S. News & World Report best hospital in cancer, cardiology, heart & vascular surgery, diabetes & endocrinology, ENT, geriatrics, neurology & neurosurgery, orthopedics, and pulmonology & lung surgery.
Recognized as a great hospital in America
UC Davis Medical Center has been recognized as one of the nation’s top hospitals by the 2023 edition of Becker’s Hospital Review’s “Great hospitals in America” list.
The nation’s highest nursing honor
UC Davis Medical Center has received Magnet® recognition, the nation’s highest honor for nursing excellence.
Ranked Sacramento’s #1 hospital
Ranked Sacramento’s #1 hospital by U.S. News, and high-performing in back surgery, COPD, colon cancer surgery, gynecological cancer surgery, heart attack, heart failure, hip fracture, kidney failure, leukemia, lymphoma & myeloma, lung cancer surgery, pneumonia, prostate cancer surgery, stroke, TAVR, and gastroenterology & GI surgery.